199 related articles for article (PubMed ID: 34330837)
1. GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.
Leurs U; Klein AB; McSpadden ED; Griem-Krey N; Solbak SMØ; Houlton J; Villumsen IS; Vogensen SB; Hamborg L; Gauger SJ; Palmelund LB; Larsen ASG; Shehata MA; Kelstrup CD; Olsen JV; Bach A; Burnie RO; Kerr DS; Gowing EK; Teurlings SMW; Chi CC; Gee CL; Frølund B; Kornum BR; van Woerden GM; Clausen RP; Kuriyan J; Clarkson AN; Wellendorph P
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330837
[TBL] [Abstract][Full Text] [Related]
2. The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction.
Griem-Krey N; Gauger SJ; Gowing EK; Thiesen L; Frølund B; Clarkson AN; Wellendorph P
Biomed Pharmacother; 2022 Dec; 156():113895. PubMed ID: 36274464
[TBL] [Abstract][Full Text] [Related]
3. The GHB analogue HOCPCA improves deficits in cognition and sensorimotor function after MCAO via CaMKIIα.
Griem-Krey N; Klein AB; Clausen BH; Namini MR; Nielsen PV; Bhuiyan M; Nagaraja RY; De Silva TM; Sobey CG; Cheng HC; Orset C; Vivien D; Lambertsen KL; Clarkson AN; Wellendorph P
J Cereb Blood Flow Metab; 2023 Aug; 43(8):1419-1434. PubMed ID: 37026450
[TBL] [Abstract][Full Text] [Related]
4. CaMKIIα as a Promising Drug Target for Ischemic Grey Matter.
Griem-Krey N; Clarkson AN; Wellendorph P
Brain Sci; 2022 Nov; 12(12):. PubMed ID: 36552099
[TBL] [Abstract][Full Text] [Related]
5. Novel cyclic gamma-hydroxybutyrate (GHB) analogs with high affinity and stereoselectivity of binding to GHB sites in rat brain.
Wellendorph P; Høg S; Greenwood JR; de Lichtenberg A; Nielsen B; Frølund B; Brehm L; Clausen RP; Bräuner-Osborne H
J Pharmacol Exp Ther; 2005 Oct; 315(1):346-51. PubMed ID: 16014570
[TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1.
Thiesen L; Kehler J; Clausen RP; Frølund B; Bundgaard C; Wellendorph P
J Pharmacol Exp Ther; 2015 Aug; 354(2):166-74. PubMed ID: 25986445
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic imaging and quantification of the high-affinity GHB binding sites in rodent brain using
Klein AB; Bay T; Villumsen IS; Falk-Petersen CB; Marek A; Frølund B; Clausen RP; Hansen HD; Knudsen GM; Wellendorph P
Neurochem Int; 2016 Nov; 100():138-145. PubMed ID: 27615059
[TBL] [Abstract][Full Text] [Related]
8. Molecular Hybridization of Potent and Selective γ-Hydroxybutyric Acid (GHB) Ligands: Design, Synthesis, Binding Studies, and Molecular Modeling of Novel 3-Hydroxycyclopent-1-enecarboxylic Acid (HOCPCA) and trans-γ-Hydroxycrotonic Acid (T-HCA) Analogs.
Krall J; Jensen CH; Bavo F; Falk-Petersen CB; Haugaard AS; Vogensen SB; Tian Y; Nittegaard-Nielsen M; Sigurdardóttir SB; Kehler J; Kongstad KT; Gloriam DE; Clausen RP; Harpsøe K; Wellendorph P; Frølund B
J Med Chem; 2017 Nov; 60(21):9022-9039. PubMed ID: 29028338
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CaMKIIα holoenzyme stability.
Torres-Ocampo AP; Özden C; Hommer A; Gardella A; Lapinskas E; Samkutty A; Esposito E; Garman SC; Stratton MM
Protein Sci; 2020 Jun; 29(6):1524-1534. PubMed ID: 32282091
[TBL] [Abstract][Full Text] [Related]
10. Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain.
Tian Y; Shehata MA; Gauger SJ; Veronesi C; Hamborg L; Thiesen L; Bruus-Jensen J; Royssen JS; Leurs U; Larsen ASG; Krall J; Solbak SMØ; Wellendorph P; Frølund B
J Med Chem; 2022 Nov; 65(22):15066-15084. PubMed ID: 36346645
[TBL] [Abstract][Full Text] [Related]
11. Radiosynthesis and Evaluation of [
Jensen CH; Hansen HD; Bay T; Vogensen SB; Lehel S; Thiesen L; Bundgaard C; Clausen RP; Knudsen GM; Herth MM; Wellendorph P; Frølund B
ACS Chem Neurosci; 2017 Jan; 8(1):22-27. PubMed ID: 28095676
[TBL] [Abstract][Full Text] [Related]
12. Variation in assembly stoichiometry in non-metazoan homologs of the hub domain of Ca
McSpadden ED; Xia Z; Chi CC; Susa AC; Shah NH; Gee CL; Williams ER; Kuriyan J
Protein Sci; 2019 Jun; 28(6):1071-1082. PubMed ID: 30942928
[TBL] [Abstract][Full Text] [Related]
13. Ca2+/CaM dependent protein kinase II (CaMKII)α and CaMKIIβ hub domains adopt distinct oligomeric states and stabilities.
Özden C; MacManus S; Adafia R; Samkutty A; Torres-Ocampo AP; Garman SC; Stratton MM
Protein Sci; 2024 Apr; 33(4):e4960. PubMed ID: 38501502
[TBL] [Abstract][Full Text] [Related]
14. GHB receptor targets in the CNS: focus on high-affinity binding sites.
Bay T; Eghorn LF; Klein AB; Wellendorph P
Biochem Pharmacol; 2014 Jan; 87(2):220-8. PubMed ID: 24269284
[TBL] [Abstract][Full Text] [Related]
15. Ca(2+)/calmodulin-dependent protein kinase II interacts with group I metabotropic glutamate and facilitates receptor endocytosis and ERK1/2 signaling: role of β-amyloid.
Raka F; Di Sebastiano AR; Kulhawy SC; Ribeiro FM; Godin CM; Caetano FA; Angers S; Ferguson SS
Mol Brain; 2015 Mar; 8():21. PubMed ID: 25885040
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Optimization of 5-Hydroxy-Diclofenac toward a New Class of Ligands with Nanomolar Affinity for the CaMKIIα Hub Domain.
Tian Y; Shehata MA; Gauger SJ; Ng CKL; Solbak S; Thiesen L; Bruus-Jensen J; Krall J; Bundgaard C; Gibson KM; Wellendorph P; Frølund B
J Med Chem; 2022 May; 65(9):6656-6676. PubMed ID: 35500061
[TBL] [Abstract][Full Text] [Related]
17. Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2.
Robison AJ; Bass MA; Jiao Y; MacMillan LB; Carmody LC; Bartlett RK; Colbran RJ
J Biol Chem; 2005 Oct; 280(42):35329-36. PubMed ID: 16120608
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a central Ca2+/calmodulin-dependent protein kinase IIalpha/beta binding domain in densin that selectively modulates glutamate receptor subunit phosphorylation.
Jiao Y; Jalan-Sakrikar N; Robison AJ; Baucum AJ; Bass MA; Colbran RJ
J Biol Chem; 2011 Jul; 286(28):24806-18. PubMed ID: 21610080
[TBL] [Abstract][Full Text] [Related]
19. Mammalian Target of Rapamycin (mTOR) Tagging Promotes Dendritic Branch Variability through the Capture of Ca2+/Calmodulin-dependent Protein Kinase II α (CaMKIIα) mRNAs by the RNA-binding Protein HuD.
Sosanya NM; Cacheaux LP; Workman ER; Niere F; Perrone-Bizzozero NI; Raab-Graham KF
J Biol Chem; 2015 Jun; 290(26):16357-71. PubMed ID: 25944900
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent modulation of the interaction between CaMKIIα and Abi1 and its involvement in spine maturation.
Park E; Chi S; Park D
J Neurosci; 2012 Sep; 32(38):13177-88. PubMed ID: 22993434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
